Cannabis firm Rua Bioscience targets October NZX listing

Cannabis firm Rua Bioscience targets October NZX listing
Brent Melville
Medicinal cannabis firm Rua Bioscience has signalled it will head to the NZX this October, breaking an initial public offering drought that has persisted since Napier Port listed in August last year.Chair Trevor Burt said the East Coast-based cannabis company, one of the first in New Zealand to be licensed for commercial production, is aiming for an IPO in the latter part of the year, “subject to market conditions and other company developments.”He said while the number of shares and price range are “yet to be decided,&rd...

More Markets

Summerset anticipates flat 1H underlying profit
Markets

Summerset anticipates flat 1H underlying profit

The company is NZ's best-performing retirement village operator.

Infratil's CDC investment cracks $5 billion mark
Markets

Infratil's CDC investment cracks $5 billion mark

Surging datacentre demand and expanded development plans benefit Infratil.

Aussie shares rise for first time in new financial year
Markets

Aussie shares rise for first time in new financial year

The ASX200 finished up 0.3% after better-than-expected domestic retail sales data.

AAP 7:45am
Soft tissue repair company Aroa could unlock $1.6b market
Markets

Soft tissue repair company Aroa could unlock $1.6b market

A transformational year is predicted for Aroa with potential for maiden profit.